Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05382026
Other study ID # 3228
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 24, 2022
Est. completion date August 31, 2023

Study information

Verified date November 2022
Source University of Saskatchewan
Contact Philip Chilibeck, PhD
Phone 306-966-1072
Email phil.chilibeck@usask.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Canada's Food Guide places an increased emphasis on plant-based proteins; however, Canadians who consume a plant-based diet may be compromised because of intake of lower-quality protein. Consumption of high-quality protein is important during growth and development, especially in highly active individuals. The study will compare milk (i.e. high quality protein) to a pea-based beverage (i.e. lower quality plant-based protein) in adolescent boys and girls who are engaged in resistance-training programs as part of their athletic training. One-hundred and fourteen adolescent boys and girls (12-17y of age) will be divided into groups that consume milk, a pea-beverage, or a carbohydrate (sugar) beverage after resistance training sessions performed three times per week for six months. It is predicted that the group consuming milk will have greater increases in muscle mass, strength, and bone density, and greater reductions in fat mass compared to the groups consuming a pea-based or carbohydrate beverages.


Description:

Milk protein is important especially for very active people and in the context of plant-based diets, which are lower in protein quality. The purpose of the study is to compare the effectiveness of milk supplementation to pea-beverage supplementation during resistance training programs for increasing lean tissue mass in adolescent boys and girls. Secondary and tertiary outcomes include fat mass, bone mineral density, and muscular strength. It is hypothesized that milk supplementation during resistance training will be more effective than plant-based proteins (i.e. pea-beverage) for increasing muscle mass, reducing fat mass, and improving bone mineral outcomes in adolescent boys and girls. One-hundred and fourteen boys and girls (aged 12-17y) who are currently enrolled in resistance training programs (3 times per week for 6 months) as part of their competitive athletic programs will be stratified by sex and maturity status before being randomized to three groups: 1) 1% chocolate milk supplementation; 2) pea-based beverage; 3) carbohydrate beverage (placebo control). Beverages will be consumed during recovery from each resistance training session (i.e. 250 ml immediately after training and 250 ml one hour later to optimize post-exercise protein synthesis) over the six-month intervention. It is anticipated that milk supplementation will be more effective than plant-based protein supplementation.


Recruitment information / eligibility

Status Recruiting
Enrollment 114
Est. completion date August 31, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 17 Years
Eligibility Inclusion Criteria: - Currently participating in a resistance-training program 3 times per week - Female participants must have reached menarche Exclusion Criteria: - Have taken any nutritional supplement (e.g., protein, creatine, amino acids) within the past month - Currently taking anabolic steroids or oral corticosteroids - Allergies to dairy, almonds, cashews, or peas

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nutritional supplementation during a 6 month resistance training program
1% chocolate milk
Nutritional supplementation during a 6 month resistance training program
Pea-based beverage
Nutritional supplementation during a 6 month resistance training program
Maltodextrin placebo

Locations

Country Name City State
Canada University of Saskatchewan Saskatoon Saskatchewan

Sponsors (1)

Lead Sponsor Collaborator
University of Saskatchewan

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in lean tissue mass (kg) Lean tissue mass measured by dual energy X-ray absorptiometry 6 months
Secondary Change in fat mass (kg) Fat mass measured by dual energy X-ray absorptiometry 6 months
Secondary Change in lumbar spine bone mineral density (g/cm-squared) Lumbar spine bone mineral density measured by dual energy X-ray absorptiometry 6 months
Secondary Change in hip bone mineral density (g/cm-squared) Hip bone mineral density measured by dual energy X-ray absorptiometry 6 months
Secondary Change in bench press strength (kg) Bench press strength predicted from resistance lifted for 6-10 repetitions 6 months
Secondary Change in squat strength (kg) Squat strength predicted from resistance lifted for 6-10 repetitions 6 months
Secondary Change in cross-sectional moment of inertia at the hip (cm to the power of 4) Cross-sectional moment of inertia measured by dual energy X-ray absorptiometry 6 months
Secondary Change in section modulus at the hip (cm to the power of 3) Section modulus measured by dual energy X-ray absorptiometry 6 months
Secondary Change in cross-sectional area at the hip (cm-squared) Cross-sectional area measured by dual energy X-ray absorptiometry 6 months
Secondary Change in cortical thickness at the hip (cm) Cortical thickness measured by dual energy X-ray absorptiometry 6 months
Secondary Change in buckling ratio at the hip (no units) Buckling ratio measured by dual energy X-ray absorptiometry 6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03662555 - Effect of Neuromuscular Electrical Stimulation Combined With Blood Flow Restriction on Muscular and Cardiovascular Function N/A
Completed NCT00060970 - Evaluating Muscle Function After Ankle Surgery N/A
Recruiting NCT05211986 - Safety and Tolerability of IMMUNA(IMM01-STEM) in Patients With Muscle Atrophy Related to Knee Osteoarthritis. Phase 1/Phase 2
Completed NCT05115643 - Brain and Muscle Plasticity During Immobilization N/A
Completed NCT03797781 - Protein Ingestion and Skeletal Muscle Atrophy N/A
Completed NCT03299972 - Multidisciplinary Research Into the Effects of Resistance Exercise and Whey Protein Supplementation in Healthy Older Men N/A
Completed NCT05072652 - Short Term Immobilization of the Lower Limb N/A
Recruiting NCT05735236 - Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation N/A
Recruiting NCT04199936 - Postoperative Electrical Muscle Stimulation (POEMS) N/A
Recruiting NCT05314413 - Examining Sex-based Differences in Metabolic and Mechanistic Responses to Disuse Induced Muscle Atrophy N/A
Recruiting NCT05823857 - Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain N/A
Recruiting NCT04900701 - The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults. N/A
Completed NCT04772040 - Impact of Fish Oil Dose on Tissue Content and Function N/A
Completed NCT06088550 - Effect of Branched-chain Amino Acid Supplementation and Exercise on Muscle Quantity and Quality in Cirrhosis N/A
Enrolling by invitation NCT04456530 - Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study Phase 2/Phase 3
Recruiting NCT03551990 - Influence of Motor Proteins on Muscle Atrophy in Cancer Patients N/A
Recruiting NCT05206253 - Effectiveness of Egg Versus Whey Protein Powder During Resistance Training N/A
Withdrawn NCT03069781 - The Effects of 17β-estradiol on Skeletal Muscle Early Phase 1
Recruiting NCT02221804 - The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT01991171 - Effectiveness of the Kinesio Taping® in Muscle Activation N/A